Jul 22, 2025, 01:00 AM by User Not Found

Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing.

Jul 21, 2025, 09:17 AM by

PhenoTips, a leading provider of precision medicine software, announces today the appointment of Parker Lachance as VP of Revenue. Parker Lachance brings to PhenoTips an extensive history scaling start-ups through sales, marketing, and customer success strategy, most recently as Vice President of Revenue Operations at Smile Digital Health.

Jul 18, 2025, 01:00 AM by User Not Found

Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited.

Jul 17, 2025, 08:13 AM by

Jul 17, 2025, 08:13 AM by

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies

Jul 17, 2025, 08:13 AM by

Huateng Pharma spotlights N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7), a versatile compound used in drug synthesis and biomedical research. Known for its role in HDAC inhibitor development, the compound also shows potential in metal chelation, antioxidant activity, and enzyme modulation. Huateng Pharma supports ongoing pharmaceutical innovation by providing high-purity intermediates like this for global research and development.

Jul 17, 2025, 08:13 AM by

Dear GenomeWeb Editorial Team, I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the upcoming BioFestival at Harvard University, taking place on October 18, 2025. We believe this event will resonate strongly with your audience, especially those engaged in life sciences, academic research, and biotech innovation. The press release highlights Zymo Research’s partnership with Harvard to celebrate disruptive research, foster academic-industry collaboration, and promote sustainable scientific innovation. With over $9,000 in cash awards and $20,000 in research funding at stake, this event empowers students to advance their research and connect with leaders in the life science community. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/harvard-university-biofestival

Jul 17, 2025, 08:13 AM by

This momentum reflects the company’s strong role as a trusted partner to major laboratories worldwide as it helps them to unlock the clinical, operational, and financial value of AI-driven pathology at scale.

Jul 16, 2025, 09:41 AM by

Jul 16, 2025, 09:41 AM by

BIOPHARMA PEG has received FDA Drug Master File (DMF) numbers for two PEG-based intermediates: mPEG-pALD 20K (DMF 040600) and HZ-PEG-HZ (1K) (DMF 041864). These compounds are commonly used in drug conjugation, controlled release, and nanoparticle modification applications, and their DMF listings provide regulatory support for pharmaceutical development.

Jul 16, 2025, 09:41 AM by

Jul 16, 2025, 09:41 AM by

Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy outcome and expansion to larger global patient studies

Jul 16, 2025, 09:41 AM by

Vector Laboratories and Navinci launched the Glysite™ Explorer in situ PLA Glycan Detection Kit, the first commercially available tool to spatially detect protein glycosylation in FFPE tissues and fixed cells. By combining Vector’s validated lectins with Navinci’s in situ PLA technology, the kit offers researchers a streamlined, reproducible way to study glycan-protein proximity and gain deeper insight into disease biology and biomarker discovery.

Jul 16, 2025, 01:00 AM by User Not Found

Bio-IT World | In recent years, phosphorylated tau has garnered so much attention as one of the “bad guys” of Alzheimer’s disease that the scientific community may have developed a bit of tunnel vision. A medical doctor in Sweden seeks to remedy the situation as a “champion” of the biomarker based on the critical if forgotten physiological role it plays in the healthy human brain.

Jul 15, 2025, 09:16 AM by

Jul 15, 2025, 09:16 AM by

New publication addresses IV therapy silent threat, identifies ivWatch as ‘transformative tool’ in NICU patient care

Jul 15, 2025, 01:00 AM by User Not Found

Bio-IT World | Massive progress has been enabled by individual applications of artificial intelligence (AI) and machine learning (ML) in drug discovery, AlphaFold being one of the most prominent, due to their ability to predict the type of molecules that should have a positive impact on patient care.

Jul 10, 2025, 10:15 AM by

VieCure announced a strategic partnership with Guardant Health to embed Guardant’s next-generation sequencing-based precision oncology tests into the VieCure Halo Intelligence platform.

Jul 10, 2025, 10:15 AM by

PubHive wins GHP's 2025 award for Most Innovative Literature Review Software, redefining life science workflows with AI-powered automation.

Jul 10, 2025, 10:15 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the 48 mg, multiple ascending dose (MAD) cohort of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR), for the treatment of obesity. Top-line data is expected in the fourth quarter of 2025.